Further studies are needed to identify the underlying mechanisms regulated by IFIT2 in resistant breast cancer cells and to investigate the therapeutic effects of IFIT2 on a variety of cancer types possessing high CSCs and expressing resistance. This evidence concerns the gene IFIT2 and cancer.